Home › NDC Lookup › Ingredients › Losartan Potassium › 00054-0123-22
⚪image loading
(from DailyMed)

Losartan Potassium 25 mg Tablet, 90-count — NDC 0054-0123-22 (Billing 00054-0123-22)

by Hikma Pharmaceuticals USA Inc. · 90 TABLET in 1 BOTTLE

This is a package of 90 tablets of Losartan Potassium 25 mg Tablet from Hikma Pharmaceuticals USA Inc., no longer marketed, no longer in the FDA NDC Directory; retail pharmacies pay about $0.0542 per tablet (NADAC). It is this product's only package size.

NDC 00054-0123-22
🏷️ FDA NDC (as labeled) 0054-0123-22 billing pads the labeler segment with a zero
Rx only Generic Discontinued Non-controlled ⚠ Discontinued by firm ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Mar 13, 2024 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 0054-0123-22 alone.

Record
FDA NDC Directory package listing · Human prescription drug
Code segments
0054 labeler · 0123 product · 22 package
Billing quantity
90 EA per package
Barcode (UPC-A, from the NDC)
3 0054012322 2
FDA record last changed
Mar 13, 2024
⚠️
Excluded from the active FDA NDC Directory. The labeler reported this product as discontinued, so it is excluded from the active NDC Directory. The listing was last certified through Oct 2022. A label may still appear on DailyMed, but the NDC is no longer in the current FDA NDC Directory. Search the FDA NDC Directory ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 0054-0123-22
Product NDC 0054-0123
11-digit billing NDC 00054012322
NCPDP billing unit EA — each (per item)
Application # ANDA077459
Established class (EPC) Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker
DEA schedule Non-controlled
Marketing category ANDA
Marketing status Discontinued
FDA listing status Discontinued by firm (certified through Oct 2022)
Route ORAL
Dosage form TABLET
Substance LOSARTAN POTASSIUM

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GCN Seq No 023381
GCN 14850
HICL code 009829
Ingredient (HICL) Losartan Potassium
HIC1 code A
Therapeutic class — broad (HIC1) Cardiovascular System
HIC2 code A4
Therapeutic class — intermediate (HIC2) Antihypertensives
HIC3 code A4F
Therapeutic class — specific (HIC3) Antihypertensives, Angiotensin Receptor Antagonist
AHFS code 24:32.08.00
AHFS class Angiotensin Ii Receptor Antagonists
FDB label name LOSARTAN POTASSIUM 25 MG TAB
FDB brand name Losartan Potassium
Legend status F — Federal legend — prescription drug or device
Quick answers
  • GSN (GCN sequence number): 023381
  • GCN: 14850
  • HICL (First Databank): 009829
  • AHFS class code: 24:32.08.00
Why two NDCs? The FDA registers this code as 0054-0123-22 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00054-0123-22. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

Label name LOSARTAN POTASSIUM 25 MG TAB Ingredient Losartan Potassium
📖 What it is MedlinePlus · NLM

Losartan is used alone or in combination with other medications to treat high blood pressure. Losartan is also used to decrease the risk of stroke in people who have high blood pressure and a heart condition called left ventricular hypertrophy (enlargement of the walls of the left side of the heart). Losartan may not decrease the risk of stroke in African Americans who have these conditions. This medication is also used to treat kidney disease in people who have type 2 diabetes (condition in which the body does not use insulin normally and therefore cannot control the amount of sugar in the bl...

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • Losartan is used mainly to treat high blood pressure in adults and children 6 and older. It's also used to lower the risk of stroke in people who have high blood pressure and an en...
  • Cough is much less common with losartan than with ACE inhibitors (like lisinopril). In clinical trials, the rate of cough with losartan was similar to that seen with a placebo. So...
  • Does losartan cause a cough like some other blood pressure medicines?
  • It's best to check with your doctor or pharmacist first. NSAIDs like ibuprofen and naproxen can reduce how well losartan controls your blood pressure, and they can also put extra s...
📖 Read our full Losartan guide →
1
Nutrient depletion considerations

Losartan Potassium may be associated with lower levels of 1 nutrient — worth a chat with your pharmacist, not a cause for alarm.

🧪 Full Losartan Potassium nutrient depletion report →
An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.054 $4.88 / 90 tablets
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per ea) — tap or hover for the price & month
Dec 2021 Feb 2022 Apr 2022 Jun 2022 $0.061 $0.050
▲ Up 9% over the last 7 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
00054-0123-22 You're viewing this Main listing 90 TABLET in 1 BOTTLE 2020-07-13 — Discontinued by firm

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
LOSARTAN POTASSIUM 25 mg 64380-0933-04 Strides 30 tablets $0.021 AB Availability likely save 61%
Losartan Potassium 25 mg 00904-7047-61 Major 1 tablet $0.022 AB Availability likely save 60%
Losartan Potassium 25 mg 11788-0100-10 AiPing 1000 tablets $0.022 AB Availability likely save 60%
Losartan Potassium 25 mg 31722-0700-05 Camber 500 tablets $0.022 AB Availability likely save 60%
Losartan Potassium 25 mg 43547-0360-09 Solco 90 tablets $0.022 AB Availability likely save 60%
Losortan Potassium 25 mg 50268-0504-15 AvPAK 1 tablet $0.022 AB Availability likely save 60%
Losartan Potassium 25 mg 62332-0027-30 Alembic 30 tablets $0.022 AB Availability likely save 60%
Losartan Potassium 25 mg 68084-0346-01 American 1 tablet $0.022 AB Availability likely save 60%
Losartan Potassium 25 mg 70010-0741-03 Granules 30 tablets $0.022 AB Availability likely save 60%
Losartan potassium 25 mg 72205-0141-90 Novadoz 90 tablets $0.022 AB Availability likely save 60%
Losartan Potassium 25 mg 72603-0340-01 NorthStar 90 tablets $0.022 AB Availability likely save 60%
Losartan Potassium 25 mg 82009-0042-10 Quallent 1000 tablets $0.022 AB Availability likely save 60%
Losartan potassium 25 mg 33342-0044-07 Macleods 30 tablets $0.031 AB FDA listed save 42%
Losartan Potassium 25 mg 42571-0110-10 Micro 1000 tablets $0.031 — Discontinued save 42%
Losartan Potassium 25 mgthis 00054-0123-22 Hikma 90 tablets $0.054 — Discontinued —
Cozaar 25 mg 78206-0121-01 Organon 90 tablets $3.364 AB Availability likely +6107%
Losartan Potassium 25 mg 00615-7958-05 NCS 15 tablets — AB FDA listed —
Losartan Potassium 25 mg 29300-0144-01 Unichem 100 tablets — AB FDA listed —
Losartan Potassium 25 mg 42708-0125-30 QPharma, 30 tablets — AB FDA listed —
Losartan Potassium 25 mg 42708-0151-30 QPharma, 30 tablets — AB FDA listed —
Losartan Potassium 25 mg 46708-0445-30 Alembic 30 tablets — AB FDA listed —
Losartan Potassium 25 mg 50090-2622-00 A-S 30 tablets — AB FDA listed —
Losartan Potassium 25 mg 50090-4645-00 A-S 30 tablets — AB FDA listed —
Losartan Potassium 25 mg 50090-5626-00 A-S 30 tablets — AB FDA listed —
Losartan Potassium 25 mg 50090-6714-00 A-S 90 tablets — AB FDA listed —
Losartan Potassium 25 mg 50090-7794-00 A-S 30 tablets — AB FDA listed —
Losartan Potassium 25 mg 50090-7795-00 A-S 90 tablets — AB FDA listed —
Losartan Potassium 25 mg 50090-7888-00 A-S 90 tablets — AB FDA listed —
Losartan Potassium 25 mg 51655-0918-26 Northwind 90 tablets — AB FDA listed —
Losartan Potassium 25 mg 55154-2326-00 Cardinal 1 tablet — AB FDA listed —
Losartan Potassium 25 mg 55154-4783-00 Cardinal 1 tablet — AB FDA listed —
Losartan potassium Tablets, 25 mg 59746-0333-01 Jubilant 100 tablets — AB FDA listed —
Losartan Potassium 25 mg 62207-0741-49 Granules 1000 tablets — AB FDA listed —
Losartan Potassium 25 mg 63187-0357-30 Proficient 30 tablets — AB FDA listed —
Losartan potassium Tablets, 25 mg 63629-2426-01 Bryant 1000 tablets — AB FDA listed —
Losartan Potassium 25 mg 65841-0729-01 Zydus 100 tablets — AB FDA listed —
Losartan Potassium 25 mg 65862-0201-05 Aurobindo 500 tablets — — FDA listed —
Losartan Potassium 25 mg 67046-1088-03 Coupler 30 tablets — AB FDA listed —
Losartan potassium 25 mg 67046-1470-03 Coupler 30 tablets — AB FDA listed —
Losartan Potassium 25 mg 68071-5041-09 NuCare 90 tablets — AB FDA listed —
Losartan Potassium 25 mg 68071-5114-03 NuCare 30 tablets — AB FDA listed —
Losartan Potassium 25 mg 68071-5147-09 NuCare 90 tablets — AB FDA listed —
Losartan Potassium 25 mg 68180-0376-01 Lupin 100 tablets — AB FDA listed —
Losartan Potassium 25 mg 68382-0135-01 Zydus 100 tablets — AB FDA listed —
Losartan Potassium 25 mg 68788-4007-01 Preferred 100 tablets — AB FDA listed —
Losartan potassium 25 mg 68788-4091-03 Preferred 30 tablets — AB FDA listed —
Losortan Potassium 25 mg 68788-8639-01 Preferred 100 tablets — AB FDA listed —
Losartan Potassium 25 mg 70518-2132-00 REMEDYREPACK 30 tablets — AB FDA listed —
Losartan Potassium 25 mg 70518-3489-00 REMEDYREPACK 30 tablets — AB FDA listed —
Losartan Potassium 25 mg 70518-3894-00 REMEDYREPACK 90 tablets — AB FDA listed —
Losartan Potassium 25 mg 71205-0226-30 Proficient 30 tablets — AB FDA listed —
LOSARTAN POTASSIUM 25 mg 71205-0675-30 Proficient 30 tablets — AB FDA listed —
Losartan Potassium 25 mg 71335-1136-01 Bryant 90 tablets — — FDA listed —
Losartan Potassium 25 mg 71335-1174-01 Bryant 90 tablets — AB FDA listed —
Losartan Potassium 25 mg 71335-1582-01 Bryant 90 tablets — AB FDA listed —
Losortan Potassium 25 mg 71335-1644-01 Bryant 90 tablets — AB FDA listed —
Losartan Potassium 25 mg 71610-0155-30 Aphena 30 tablets — AB FDA listed —
Losartan Potassium 25 mg 71610-0224-30 Aphena 30 tablets — AB FDA listed —
Losartan Potassium 25 mg 71610-0439-15 Aphena 15 tablets — AB FDA listed —
Losartan potassium Tablets, 25 mg 72162-1696-00 Bryant 1000 tablets — AB FDA listed —
Losartan Potassium 25 mg 72162-2506-00 Bryant 1000 tablets — AB FDA listed —
Losartan Potassium 25 mg 72189-0082-30 DIRECT 30 tablets — AB FDA listed —
Losartan Potassium 25 mg 72189-0100-90 DIRECT 90 tablets — AB FDA listed —
Losartan Potassium 25 mg 72189-0303-90 DirectRx 90 tablets — AB FDA listed —
Losartan Potassium 25 mg 72789-0029-14 PD-Rx 14 tablets — AB FDA listed —
LOSARTAN POTASSIUM 25 mg 72789-0163-90 PD-Rx 90 tablets — AB FDA listed —
LOSARTAN POTASSIUM 25 mg 72789-0282-30 PD-Rx 30 tablets — AB FDA listed —
Losartan Potassium 25 mg 72865-0141-10 XLCare 1000 tablets — AB FDA listed —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

📍
2026
Currently FDA-listed
listed with the FDA
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Losartan inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerHikma Pharmaceuticals USA Inc.
Application holderHIKMA PHARMACEUTICALS USA INC
FDA applicationANDA077459 (ANDA)
Labeler code00054
Product typeHuman Prescription Drug
Portfolio726 products on file

More NDCs from Hikma Pharmaceuticals USA Inc. labeler code 00054

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

Full prescribing information FDA SPL

The complete FDA label for this product — the official prescribing information, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
📄 FDA label
📄 FDA label 19 words ▾

No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.

Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Losartan Potassium — the program that covers self-administered drugs. 20 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Losartan Potassium. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$87.55M
Claims incl. refills
9.7M
Beneficiaries
7.6M
Spend / beneficiary
$11.46
Spend / claim
$8.99
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

About this NDC listing & data coverage

Finished prescription product No longer marketed (per FDA listing data)
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) — Not published for this NDC No structured label is linked to this listing in DailyMed/openFDA.
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) ✓ Available
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Why is there no full label on this page?
No structured FDA label (SPL) is currently linked to this NDC in DailyMed/openFDA. That can happen with older listings, certain OTC and repackaged products, and recently updated listings whose label has not yet propagated. The listing itself is still valid — this page shows everything the public feeds provide for this package.
What does the discontinued status mean for this NDC?
The labeler reported a marketing end date (or the listing was delisted), so this specific package is no longer actively marketed. Remaining stock may still be dispensed for a time, and the NDC stays valid for historical records and claims — but data feeds (pricing, labeling) typically stop updating for it. Other package sizes or other manufacturers' versions of the same medication may still be marketed — see the equivalents section where available.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Who lists this product with the FDA?
Hikma Pharmaceuticals USA Inc. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as a prescription product, so it is dispensed under a prescriber's order. Your pharmacist can tell you whether any over-the-counter forms of the same medication exist.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 00054-0109-25 · Hikma 00054-0137-49 · Hikma →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.